Jerusalem Pharmaceuticals
Jerusalem, Israel· Est.
Jerusalem Pharmaceuticals is an Israel‑based biotech developing innovative oncology and immunology therapeutics using a proprietary discovery platform.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Jerusalem Pharmaceuticals is an Israel‑based biotech developing innovative oncology and immunology therapeutics using a proprietary discovery platform.
OncologyImmunology
Technology Platform
Proprietary AI‑enhanced drug discovery platform integrating high‑throughput screening, multi‑omics data, and structure‑based design to accelerate lead identification and optimization.
Opportunities
Advancing pre‑clinical candidates into IND‑enabling studies and leveraging strategic partnerships with larger pharma to accelerate clinical development.
Risk Factors
Scientific uncertainty of early‑stage assets, need for substantial follow‑on financing, and competitive pressure from established oncology biotech firms.
Competitive Landscape
Competes with global and Israeli oncology/ immunology biotech firms; differentiation hinges on novel mechanisms of action and AI‑driven discovery efficiency.